Natalie C. Diaz is an associate within the Cannabis, Hemp, and Psychedelics (“CHAP”) Practice Group at Mandelbaum Barrett PC. With a sharp understanding of the intricacies within the CHAP industries, Natalie guides both individuals and businesses through various legal matters including license acquisition, regulatory compliance, commercial real estate, and corporate transactions. Her dedication lies in providing robust legal representation while ensuring her clients possess a comprehensive understanding of their rights within these sectors.
Natalie earned her Juris Doctor from Widener University Delaware Law School, supported by scholarships from diverse bar associations. Before embarking on her legal studies, she was a legal assistant for three years where she accumulated valuable experience in employment law, personal injury cases, and administrative law. She also played a role in advocating for policy reforms benefiting college athletes.
Throughout her time in law school, Natalie undertook internships at the United States District Court for the District of New Jersey and the New Jersey Division of Law, where she worked alongside the Deputy Attorneys General. Her noteworthy contributions include providing legal aid to victims of domestic violence and individuals navigating special needs education law during the challenges posed by the COVID-19 pandemic.
Beyond her professional endeavors, Natalie is deeply committed to advocating for social justice and equality within the cannabis community. In her personal life, she devotes her time to volunteering, practicing yoga, engaging in fitness activities, exploring nature through hiking, traveling to experience diverse cultures, and supporting environmental preservation efforts.
Primerus 2024 Northeast Regional Meeting – “Cannabis Licensing 101”
New Jersey
New York
Widener Delaware Law School, Wilmington, DE, Juris Doctor
Seton Hall University, South Orange, NJ, Bachelor of Arts, Major in Criminal Justice
Supporting a Client in Securing Funding for New York CAURD License
December 12, 2024
The Firm’s Cannabis, Hemp, and Psychedelic Practice Group (“CHAP”) is proud to announce a significant milestone in advancing New York’s emerging cannabis industry. This month, attorneys Joshua S. Bauchner, Natalie C. Diaz, and Shawn R. McClelland successfully facilitated a transaction securing necessary funding for a client’s Conditional Adult-Use Retail Dispensary (“CAURD”) license. Through this achievement, […]Victory for Licensed Hemp Retailer: OATH Dismisses Summons and Recommends Reopening
November 12, 2024
In a powerful affirmation of the rights of licensed hemp businesses, the NYC Office of Administrative Trials and Hearings (OATH) recently ruled in favor of our client, a state-licensed hemp retailer, following an aggressive raid and sealing by the NYC Sheriff’s Office. Represented by attorneys Joshua Bauchner and Natalie Diaz of Mandelbaum Barrett PC, the […]From Waiting to Winning
July 9, 2024
Attorney Natalie C. Diaz continues to work seamlessly with the client, advocating for their best interests and providing legal support. you can contact Natalie C. Diaz at 973-852-4235 or via email at ndiaz@mblawfirm.com At Mandelbaum Barrett PC, we are proud to have attorneys like Natalie C. Diaz, who go above and beyond to ensure our clients achieve their goals.Guns, Cannabis, and the Constitution: SCOTUS to Hear United States v. Hemani on Cannabis Use and Gun Ownership
October 20, 2025
The United States Supreme Court added another significant Second Amendment dispute to its 2025-26 calendar. On October 20, 2025, the Court granted certiorari in United States v. Hemani, a case that could shape the legal landscape for millions of Americans who use marijuana and own firearms. The Court is expected to hear oral argument in […]The NJEDA NJ LEAF Loan Program: A Vital Resource for New Jersey’s Cannabis Businesses
October 15, 2025
On September 15, 2025, the New Jersey Economic Development Authority (NJEDA) announced the launch of a $15 million pilot loan program to support the state's expanding recreational cannabis industry. The New Jersey Lending for Equity, Access, and Financing (NJ LEAF) Program is designed to provide capital to licensed cannabis cultivators, manufacturers, and testing laboratories operating in the state. Because cannabis remains a Schedule I substance under federal law, cannabis businesses are largely excluded from traditional banking services and loans. As a result, many rely on private financing, which makes it difficult to access affordable capital and cover startup costs.NEW YORK LAW JOURNAL: NY’s Current Cannabis Legal Landscape: Progress, Paralysis, or Both?
October 3, 2025
In their recent piece for the New York Law Journal, Joshua S. Bauchner and Natalie C. Diaz pose a compelling question: Is New York’s cannabis program making real progress — or is it stuck in paralysis? As the state tries to move from legalization to implementation, the landscape is increasingly defined by tension: bold ambitions on paper, but messy execution in practice.NJEDA Cannabis Business Development Grant Launching This Fall – Our Firm Can Help You Apply
September 29, 2025
The New Jersey Economic Development Authority (“NJEDA”) is preparing to launch the Cannabis Business Development (“CBD”) Grant program later this fall (date to be announced). This program is specifically designed to support licensed cannabis businesses in New Jersey by offering one-time reimbursement grants of up to $75,000. The goal is to reduce financial barriers to entry and expansion in the state's growing adult-use cannabis market, particularly for independent operators.Second Circuit Ruling in Variscite v. NYCCB – Another Court Finding NYS OCM’s Regulatory Scheme Is Unconstitutional
August 20, 2025
In a pivotal ruling issued on August 12, 2025, the United States Court of Appeals for the Second Circuit vacated a lower court decision and held that portions of New York’s cannabis licensing framework violate the Dormant Commerce Clause (“DCC”) of the United States Constitution. The case, Variscite NY Four, LLC v. New York State Cannabis Control Board, presents yet another significant constitutional challenge to how states implement social equity programs within their legal cannabis industries. The decision is expected to influence state cannabis regulatory schemes and markets across the country.President Trump Confirms Marijuana Rescheduling Is Under Consideration
August 15, 2025
President Donald Trump confirmed this week that his administration is actively reviewing the possibility of reclassifying marijuana as a less dangerous drug. This move would follow through on a proposal made under the Biden administration, which began the process of shifting cannabis from Schedule I to Schedule III in 2024. However, that process was not completed before President Biden left office.Cannabis Safety in New Jersey – CRC’s Updated Testing and Compliance Standards
April 4, 2025
The cannabis industry in New Jersey is undergoing a transformation, with an increased emphasis on safety, transparency, and quality assurance. During its February 18th public meeting, the New Jersey Cannabis Regulatory Commission (“CRC”) released the full, updated cannabis lab testing guidance (the “Testing Guidance”), which provides further clarification to existing regulations to ensure consumer safety and boost public confidence in cannabis products. These measures come in response to mounting concerns about contamination, including mold, pesticides, heavy metals, and the reliability of potency claims, especially in light of the June 29, 2024, recall of various Green Joy products.New York’s Cannabis Regulations: Understanding the Amendments to Proximity Requirements and Public Convenience and Advantage Rules
March 6, 2025
New York’s Cannabis Control Board (“CCB”) amended its cannabis regulations to refine licensing criteria, adjust distance restrictions, and strengthen public convenience and advantage considerations. These amendments aim to promote economic development, ensure an orderly expansion of the market, and mitigate unintended consequences such as market oversaturation and inequitable access. The changes reflect New York’s commitment to fostering a balanced, competitive, and transparent cannabis industry while incorporating public and municipal input into the regulatory framework.Another Major Win for Hemp Retailers: Case Dismissed by NYOCM Office of Administrative Hearings
January 27, 2025
The Office of Administrative Hearings recently dismissed a notable case involving allegations of unlicensed cannabis sales, offering valuable insights into the evolving regulatory landscape for licensed hemp retailers. On January 16, 2024, the ruling brought clarity to compliance expectations and underscored the importance of due process and evidentiary burdens in enforcement actions. The case centered […]Navigating the Complexities of Cannabis and Road Safety
January 10, 2025
As the legalization of recreational cannabis continues to gain momentum across the United States, the need to address its impact on road safety has become increasingly urgent. Colorado, a pioneer in cannabis legalization, has emerged as a central hub for groundbreaking research into the effects of cannabis and driving. Federal scientists, armed with innovative tools and methods, are tackling critical questions about cannabis impairment and working to fill the gaps in our understanding. From retrofitted, tapestry-lined vans to state-of-the-art driving simulators, researchers are delving into the ways cannabis affects motor skills and reflexes in both frequent and occasional users. Their mission is clear: to provide policymakers with the evidence necessary to design fair and enforceable cannabis-driving laws that prioritize public safety while respecting individual freedoms.Season’s High-lights: Exciting Updates from the Cannabis Team
December 30, 2024
As the cannabis industry continues to evolve, our Cannabis, Hemp & Psychedelics Practice Group remains dedicated to providing cutting-edge solutions, advocating for equity, and navigating the complexities of compliance. Our latest updates showcase some of the impactful strides we’ve made recently, highlighting our commitment to supporting clients and driving positive change in the industry. In […]New Jersey CRC to Open Applications for Cannabis Consumption Areas: Key Details You Need to Know
December 17, 2024
Applications for cannabis consumption area endorsements are set to open on January 2, 2025, creating regulated spaces for adults aged 21 and older to consume cannabis products purchased at licensed dispensaries. The New Jersey Cannabis Regulatory Commission (“CRC”) approved a Notice of Adoption of the Cannabis Consumption Area Rules on January 17, 2024, via Resolution […]New York Newsletter: Winter Edition
December 16, 2024
Check out our NYC Newsletter to read about our recent successes, important legal updates, and how our team is closing out the year. 🗽📖 Read it Here.NY Court Again Enjoins Cannabis Licensure Due To OCM’s Errors In Program Administration
December 16, 2024
On December 12, 2024, the New York Supreme Court in Albany County granted an Article 78 petition seeking a preliminary injunction in the case of Organic Blooms, LLC, et al. v. New York State Cannabis Control Board and Office of Cannabis Management. This case addresses key issues in the State’s cannabis licensing program and has significant implications for the industry and regulatory practices in New York.Cannabis, Hemp & Psychedelics Newsletter
October 24, 2024
The Cannabis, Hemp, and Psychedelics Practice Group at Mandelbaum Barrett PC, chaired by Joshua S. Bauchner, released their latest newsletter on October 20th, providing key updates on their ongoing legal battles and industry insights. You can read the full newsletter here. The newsletter mentions that Mandelbaum Barrett PC’s Cannabis, Hemp, and Psychedelics Practice Group continues […]New Jersey’s New Hemp Regulations Create More Problems Than They Solve
October 16, 2024
Governor Phil Murphy’s signing of Senate Bill 3235 on September 12, 2024, represents a significant shift in the regulation of intoxicating hemp products in New Jersey. The original intention of the bill was to restrict sales to those under 21 years of age. However, lobbyists turned this simple exercise into a bill better reflecting Frankenstein’s […]U.S. Senators Reintroduce Proposed Legislation Seeking to End Federal Prohibition of Cannabis
May 20, 2024
On May 1, 2024, Senators Booker, Schumer, and Wyden reintroduced the Cannabis Administration and Opportunity Act (“CAOA”). Natalie C. Diaz, Esq., explains how this legislation aims to end federal cannabis prohibition. Reflecting overwhelming public support, the bill addresses social justice, public health, and economic empowerment, marking a comprehensive approach to cannabis reform.NYC Newsletter
May 17, 2024
the latest updates from Mandelbaum Barrett PC, straight from the vibrant streets of New York City. As we mark the midpoint of the year, our firm is excited to share significant milestones and achievements. From navigating complex legal landscapes to celebrating noteworthy victories, we're dedicated to delivering exceptional service to our clients. Join us on this journey as we reflect on our progress and look forward to what lies ahead.Reclassifying Cannabis as Schedule III: Unpacking the Impact on Taxation, Medical Research, and Social Justice
May 6, 2024
On April 30, 2024, the Associated Press shared news of the DEA's proposal to reclassify cannabis. Natalie Diaz, Associate in the Cannabis, Hemp & Psychedelics Practice Group, cautiously welcomed the move, seeing potential for better medical research and social justice. Yet, she remained watchful, knowing there were still hurdles ahead in changing cannabis laws.Breaking News: Albany County Supreme Court Invalidates New York State Cannabis Regulations
April 4, 2024
In a remarkable legal development, an Albany County Supreme Court judge has nullified all regulations for adult-use cannabis in New York State, challenging the foundational efforts of the NY Office of Cannabis Management (OCM). This decision, ruling the regulations as arbitrary and capricious, brings to light serious doubts regarding the proficiency and effectiveness of the state's cannabis regulatory framework. Originating from a lawsuit by Leafly Holdings, Stage One Dispensary, and a consumer dependent on Leafly for informed cannabis purchases, the judgement by Judge Kevin Bryant significantly impacts sections crucial for the governance of New York's adult-use cannabis market.Cannabis Department of Mandelbaum Barrett PC Announced Cannabis Law Practice of the Year Winner by New Jersey Law Journal
October 31, 2025
We’re proud to celebrate the Cannabis Department of Mandelbaum Barrett PC for being recognized by the New Jersey Law Journal as winners of the Cannabis Law Practice of the Year Award. This recognition underscores our team’s dedication to delivering strategic counsel across licensing, compliance, real estate, tax, banking, and litigation in the evolving cannabis, hemp […]Law 360: Court Rules Against Job Applicant in Cannabis Employment Case
February 6, 2025
Joshua Bauchner and Natalie Diaz of Mandelbaum Barrett PC’s Cannabis, Hemp and Psychedelics Practice Group provided this analysis for Law360. You can read their full article “Parsing 3rd Circ. Ruling On Cannabis, Employee Private Suits,” here. A recent decision by the U.S. Court of Appeals for the Third Circuit in Zanetich v. Walmart has major […]JD Supra: Navigating the Complexities of Cannabis and Road Safety
February 4, 2025
JD Supra recently featured attorneys Joshua S. Bauchner and Natalie C. Diaz from our Cannabis, Hemp, and Psychedelics practice group in an insightful article discussing the complexities of cannabis and road safety. Both attorneys provide valuable analysis on the evolving legal landscape of cannabis use and its impact on driving regulations.NJ Cannabis Regulations: Local Control and Social Equity Challenges
July 19, 2024
As New Jersey's cannabis industry continues to evolve, striking a balance between local regulatory control and equitable market access remains crucial. Applicants, especially those from "social equity" backgrounds, face significant challenges due to financial constraints and stringent local regulations. The article by Joshua S. Bauchner and Natalie C. Diaz provides a comprehensive overview of these challenges and offers valuable insights into navigating the complex regulatory environment.